Streetbeat News

Revenues

CERS

Cerus shares are trading higher after the company reported better-than-expected Q2 EPS results and raised its FY24 product revenue guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 9:20 pm

ERO

Ero Copper (NYSE:ERO) reported Q2 2024 adjusted EPS of $0.18, beating the $0.16 estimate, but sales of $117.1M missed the $120.297M estimate. EPS decreased by 25% YoY, while sales increased by 11.63% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 9:19 pm

BFS

Saul Centers (NYSE:BFS) reported Q2 earnings of $0.83 per share, beating the analyst estimate of $0.77. Sales were $66.94 million, surpassing the $65.54 million estimate. Both earnings and sales showed year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 9:19 pm

OPEN

Opendoor Technologies Inc. (OPEN) has released its Q3 revenue guidance, expecting between $1.2 billion and $1.3 billion, which is below the estimated $1.59 billion. The company also provided guidance for its Q3 contribution profit and adjusted EBITDA.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 9:17 pm

LASR

nLIGHT has provided its Q4 revenue guidance, estimating between $53 million and $58 million, compared to the analyst estimate of $55.6 million.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 9:17 pm

SEM

Select Medical Holdings (NYSE:SEM) reported Q2 2024 earnings per share (EPS) of $0.60, missing the analyst consensus estimate of $0.61 by 1.64%. However, the company reported sales of $1.760 billion, beating the estimate of $1.745 billion by 0.88%.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 9:16 pm

IAS

Integral Ad Science shares are trading higher after the company reported better-than-expected Q2 financial results and issued FY24 revenue guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 9:16 pm

OFS

OFS Capital (NASDAQ:OFS) reported Q2 2024 earnings per share (EPS) of $0.26, missing the analyst consensus estimate of $0.29 by 10.34%. The company's sales were $11.165 million, also missing the estimate of $11.740 million by 4.90%. Both EPS and sales showed significant declines compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 9:14 pm

SGHT

Sight Sciences narrows its FY24 revenue guidance from $81M-$85M to $81M-$83M, below the estimated $83.832M. The company also expects dry eye revenue for FY24 to be less than $3M. Additionally, it narrows guidance for adjusted operating expenses to $107M-$109M, a slight decrease from 2023.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 9:12 pm

BOOM

DMC Global has projected its Q3 consolidated sales to be between $158 million and $168 million.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 9:12 pm